Sihuan Pharmaceutical's (HKG:0460) trustee bought back 8 million shares of the firm from the market for around HK$1.0052 apiece under a 2022 share award scheme, according to a Wednesday filing with the Hong Kong bourse.
The company's shares fell nearly 4% in late morning trade Thursday.
The shares represent 0.0877% of the pharma firm's issued share capital.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments